Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity

Drug Metabolism and Disposition

Volumn 30, Issue 6, 2002, Pages 716-723

  Koetzner, Lee ^a   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CHOLINESTERASE; COCAINE; NOMIFENSINE; PARAOXON;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INACTIVATION; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; STEREOTYPY;

ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C3H; MOTOR ACTIVITY; PARAOXON; PSYCHOMOTOR AGITATION;

ANIMALIA;

EID: 0036263325     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.6.716     Document Type: Article

References (23)

1. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats
2. The interrelationship of succinylcholine and the blood cholinesterases during anesthesia
3. The influence of plasma butyrylcholinesterase concentration on the in vitro hydrolysis of cocaine in human plasma
4. Butyrylcholinesterase accelerates cocaine metabolism: In vitro and in vivo effects in nonhuman primates and humans
5. Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase
6. Monoclonal antibodies allow precipitation of esterasic but not peptidasic activities associated with butyrylcholinesterase
7. An introduction to the concept of stereotypy and a historical perspective on the role of brain dopamine
8. A new and rapid colorimetric determination of acetylcholinesterase activity
9. Activities of some of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase
10. Behavioral and pharmacological assessment of butyrylcholinesterase in rats
11. Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice
12. Determination of cocaine concentrations in plasma by high-performance liquid chromatography
13. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine
14. Cocaine detoxification by human plasma butyrylcholinesterase
15. Aging and spontaneous reactivation of human plasma cholinesterase activity after inhibition by organophosphorus pesticides
16. Therapeutic use of butyrylcholinesterase for cocaine intoxication
17. Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys
18. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase
19. Effect of repeated administration of various doses of cocaine and WIN 35.065-2 on locomotor behavior of mice
20. Locomotor effects of cocaine, cocaine congeners and local anesthetics in mice
21. Metabolism and kinetics of bupropion
22. Hydrolysis of cocaine in human plasma by cholinesterase
23. An improved cocaine hydrolase: The A328Y mutant of human butyrylcholinesterase is 4-fold more efficient